Return to Article Details
MELANOSIS SECONDARY TO PEGYLATED LIPOSOMAL DOXORUBICIN FOR OVARIAN CANCER TREATMENT: AN UNCOMMON EXPRESSION OF SKIN SIDE EFFECTS
Download
Download PDF